Proteomics

Dataset Information

0

Selective RNA sequestration in P-bodies regulates cell identity


ABSTRACT: Post-transcriptional regulation is pivotal in guiding the gene expression programs that instruct cell fate decisions. Recent studies emphasize the significance of biomolecular condensates in modulating gene expression through RNA processing and translational control. However, the functional roles of RNA condensates in the context of cell fate specification are unknown. In this study, we profiled the coding and non-coding transcriptome within intact biomolecular condensates known as P-bodies in diverse developmental contexts and vertebrate species. Our analyses revealed the conserved, cell type-specific sequestration of RNAs encoding key cell fate specifiers. Notably, P-body contents did not directly reflect gene expression profiles for a given cell type, but rather were enriched for transcripts characteristic of the preceding developmental stage, which are translationally suppressed and stored within P-bodies. We demonstrate that the forced degradation of P-bodies stimulates the translation of transcripts encoding fate-instructive factors, ultimately re-activating a totipotency transcriptional program in human and mouse pluripotent cells. Mechanistically, microRNAs (miRNAs) facilitate the sequestration of specific RNAs into P-bodies in a context-dependent manner. Accordingly, perturbing AGO2, alternative polyadenylation, and miRNA function profoundly reshapes the RNA content of P-bodies and alters cell fate. Furthermore, we show that adding a miRNA target sequence is sufficient to redirect transcripts to P-bodies and influence stem cell self-renewal. Collectively, our findings establish a direct link between biomolecular condensates and cell fate decisions across vertebrate species.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Embryonic Stem Cell

SUBMITTER: Alicia Richards  

LAB HEAD: DanielleL Swaney

PROVIDER: PXD058827 | Pride | 2025-05-07

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20240924_172432_exLewis006283.sne Other
20240924_172432_exLewis006283_Report.tsv Tabular
JBB1_GPF_092424.tsv Tabular
checksum.txt Txt
exLewis006274.raw Raw
Items per page:
1 - 5 of 35
altmetric image

Publications

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M<sup>Pro</sup> inhibitors with potent in vivo efficacy.

Detomasi Tyler C TC   Degotte Gilles G   Huang Sijie S   Suryawanshi Rahul K RK   Diallo Amy A   Lizzadro Luca L   Zapatero-Belinchón Francisco J FJ   Taha Taha Y TY   Li Jiapeng J   Richards Alicia L AL   Hantz Eric R ER   Alam Zain Z   Montano Mauricio M   McCavitt-Malvido Maria M   Gumpena Rajesh R   Partridge James R JR   Correy Galen J GJ   Matsui Yusuke Y   Charvat Annemarie F AF   Glenn Isabella S IS   Rosecrans Julia J   Revalde Jezrael L JL   Anderson Dashiell D   Hultquist Judd F JF   Arkin Michelle R MR   Neitz R Jeffrey RJ   Swaney Danielle L DL   Krogan Nevan J NJ   Shoichet Brian K BK   Verba Kliment A KA   Ott Melanie M   Renslo Adam R AR   Craik Charles S CS  

Science advances 20250423 17


The main protease (M<sup>Pro</sup>) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a validated drug target. Starting with a lead-like dihydrouracil chemotype identified in a large-library docking campaign, we improved M<sup>Pro</sup> inhibition >1000-fold by engaging additional M<sup>Pro</sup> subsites and using a latent electrophile to engage Cys<sup>145</sup>. Advanced leads from this series show pan-coronavirus antiviral activity, low clearance in mice, and for <b>AVI-4773  ...[more]

Similar Datasets

2024-11-30 | GSE277409 | GEO
2022-10-05 | PXD036610 | Pride
2023-11-02 | GSE232651 | GEO
2019-10-03 | PXD014828 | Pride
2022-10-04 | GSE211555 | GEO
2025-05-12 | GSE278676 | GEO
2025-05-26 | PXD057944 | Pride
2021-09-24 | PXD025053 | Pride
2025-04-15 | PXD058854 | Pride
2023-12-06 | PXD046971 | Pride